default author photo

David König

University of Basel - University Hospital Basel

SCHOLARLY PAPERS

3

DOWNLOADS

115

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Role of 18f-Fdg Pet/Ct in the Postoperative Follow-Up in Patients with Stage I-Iii Nsclc: A Retrospective Single-Institution Study

Number of pages: 23 Posted: 02 May 2022
Anna Kaumanns, David König, Marco Cattaneo, Alin Chirindel, Mark Wiese, Michael Tamm, Didier Lardinois, Sacha I. Rothschild and Aljaz Hojski
affiliation not provided to SSRN, University of Basel - University Hospital Basel, University of Basel - Department of Clinical Research, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Basel - Clinic of Pneumology and Pulmonary Cell Research, University of Basel - University Hospital Basel, University of Basel - University Hospital Basel and University of Basel - University Hospital Basel
Downloads 49 (1,074,648)

Abstract:

Loading...

Resectable non-small cell lung cancer, FDG-PET/CT, surveillance, Recurrence, Second curatively intended treatment

2.

Immunotherapy with Pembrolizumab Beyond Progression and Local Ablative Therapy in Oligoprogressive Metastatic Non-Small Cell Lung Cancer

Number of pages: 19 Posted: 06 Mar 2025
Anton Oseledchyk, Leopold Häcker, Andreas M. Schmitt, Till Wallrabenstein, Tobias Finazzi, David König and Sacha I. Rothschild
University of Basel - University Hospital Basel, affiliation not provided to SSRN, University of Basel - University Hospital Basel, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Basel - University Hospital Basel and University of Basel - University Hospital Basel
Downloads 40 (1,196,171)

Abstract:

Loading...

NSCLC, oligoprogressive disease, immune checkpoint blockade, PD-1, treatment beyond progression

3.

First-line immunotherapy +/- chemotherapy with or without upfront stereotactic radiotherapy (SRT) in patients with Non-Small Cell Lung Cancer (NSCLC) with asymptomatic brain metastases

Number of pages: 26 Posted: 19 Sep 2025
Lorenz Frehner, Sämi Schär, Stefanie Hayoz, Verena Petermichl, Philip Speicher, Sacha I. Rothschild, Laetitia A. Mauti, David König, Tobias Finazzi, Patrizia Froesch, Sabrina Marini, Anna Allemann, Michael Thomas Mark, Wolf-Dieter Janthur, Antonia Stamatiou, Yannis Metaxas, Ekin Ermis, Franca Wagner, Martin Früh and Sabine Schmid
affiliation not provided to SSRN, affiliation not provided to SSRN, Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Kantonsspital St Gallen, affiliation not provided to SSRN, University of Basel - University Hospital Basel, Cantonal Hospital Winterthur, University of Basel - University Hospital Basel, affiliation not provided to SSRN, Oncology Institute of Southern Switzerland, Oncology Institute of Southern Switzerland, affiliation not provided to SSRN, Kantonsspital Graubünden, Department of Oncology/Haematology, Cantonal Hospital Aarau, Lausanne University Hospital, affiliation not provided to SSRN, Varian Medical Systems, affiliation not provided to SSRN, Universitäres Lehrund Forschungsspital and affiliation not provided to SSRN
Downloads 26 (1,372,601)

Abstract:

Loading...

NSCLC, brain metastases, immune checkpoint inhibitors, stereotactic radiotherapy